Primary ovarian insufficiency (POI) is defined as ovarian dysfunction in women younger than 40 years. It affects 1% of the women in this age-group and can occur iatrogenically after chemotherapy. Stem cells have been used in attempt to restore ovarian function in POI. In particular, endometrial mesenchymal stem cells (eMSCs) are easily obtainable in humans and have shown great potential for regenerative medicine. Here, we studied the potential for uterine cell (UC) suspensions containing eMSCs to improve ovarian function in a murine model of chemotherapy-induced POI. Green fluorescent protein (GFP)-labeled UC or phosphate-buffered solution (PBS) was delivered intravenously after chemotherapy. There was a significant increase in oocytes production and serum anti-Müllerian hormone concentrations after 6 weeks, as well as a 19% higher body mass in UC-treated mice. Similarly, we observed an increased number of pups in mice treated with UC than in mice treated with PBS. None of the oocytes or pups incorporated GFP, suggesting that there was no contribution of these stem cells to the oocyte pool. We conclude that treatment with UC indirectly improved ovarian function in mice with chemotherapy-induced POI. Furthermore, our study suggests that endometrial stem cell therapy may be beneficial to young women who undergo ovotoxic chemotherapy.
BedoschiGNavarroPAOktayK. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol (London, England). 2016;12(20):2333–2344.
4.
OktayKHarveyBEPartridgeAH, et al.Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001.
5.
LambertiniMMooreHCFLeonardRCF, et al.Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol. 2018;36(19):1981–1990.
6.
SenraJCRoqueMTalimMCTReisFMTavaresRLC. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis. Ultrasound in Obstet Gynecol. 2018;51(1):77–86.
7.
MoawadNSSantamariaERhoton-VlasakALightseyJL. Laparoscopic ovarian transposition before pelvic cancer treatment: ovarian function and fertility preservation. J Minim Invasive Gynecol. 2017;24(1):28–35.
8.
LeeHJSelesniemiKNiikuraY, et al.Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol. 2007;25(22):3198–3204.
9.
FuXHeYXieCLiuW. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy. 2008;10(4):353–363.
10.
WangFWangLYaoXLaiDGuoL. Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure. Stem cell Res Ther. 2013;4(5):124.
11.
LaiDWangFChenYWangLWangYChengW. Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility. BMC Develop Biol. 2013;13:34.
12.
TaylorHS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004;292(1):81–85.
13.
DuHTaylorHS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells. 2007;25(8):2082–2086.
14.
DuHTaylorHS. Stem cells and female reproduction. Reprod Sci. 2009;16(2):126–139.
15.
DuHNaqviHTaylorHS. Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem cells and Develop. 2012;21(18):3324–3331.
16.
WolffEFWolffABHonglingDTaylorHS. Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis. Reprod Sci. 2007;14(6):524–533.
WolffEFMutluLMassasaEEElsworthJDEugene RedmondDJrTaylorHS. Endometrial stem cell transplantation in MPTP-exposed primates: an alternative cell source for treatment of Parkinson’s disease. J Cell and Mol Med. 2015;19(1):249–256.
19.
SantamariaXMassasaEEFengYWolffETaylorHS. Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Mol Ther. 2011;19(11):2065–2071.
20.
WolffEFGaoXBYaoKV, et al.Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model. J Cell and Mol Med. 2011;15(4):747–755.
21.
MutluLHufnagelDTaylorHS. The endometrium as a source of mesenchymal stem cells for regenerative medicine. Biol Reprod. 2015;92(6):138.
22.
ZouKYuanZYangZ, et al.Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol. 2009;11(5):631–636.
23.
JohnsonJCanningJKanekoTPruJKTillyJL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428(6979):145–150.
24.
MassasaEETaylorHS. Use of endometrial stem cells in regenerative medicine. Regen Med. 2012;7(2):133–135.
25.
Sahin ErsoyGZolbinMMCosarEMoridiIMamillapalliRTaylorHS. CXCL12 promotes stem cell recruitment and uterine repair after injury in Asherman’s syndrome. Mol Ther Meth Clin Dev. 2017;4:169–177.
26.
HerraizSBuiguesADiaz-GarciaC, et al.Fertility rescue and ovarian follicle growth promotion by bone marrow stem cell infusion. Fertil Steril. 2018;109(5):908–918.e902.
27.
LiuJZhangHZhangY, et al.Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats. Mol Cells. 2014;37(12):865–872.
28.
KilicSPinarliFOzogulCTasdemirNNaz SaracGDelibasiT. Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty. Gynecol Endocrinol. 2014;30(2):135–140.
29.
LiuTHuangYZhangJ, et al.Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model. Stem cells Dev. 2014;23(13):1548–1557.
30.
GradySTWattsAEThompsonJAPenedoMCTKongantiKHinrichsK. Effect of intra-ovarian injection of mesenchymal stem cells in aged mares. J Assist Reprod Genet. 2018.
31.
FazeliZAbedindoAOmraniMDGhaderianSMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Rev. 2018;14(1):1–12.
32.
MohamedSAShalabySMAbdelazizM, et al.Human mesenchymal stem cells partially reverse infertility in chemotherapy-induced ovarian failure. Reprod Sci. 2018;25(1):51–63.
33.
SunMWangSLiY, et al.Adipose-derived stem cells improved mouse ovary function after chemotherapy-induced ovary failure. Stem Cell Res Ther. 2013;4(4):80.
34.
LaiDWangFYaoXZhangQWuXXiangC. Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure. J Trans Med. 2015;13:155.
35.
TillyJLTelferEE. Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock?Mol Hum Reprod. 2009;15(7):393–398.
36.
WhiteYAWoodsDCTakaiYIshiharaOSekiHTillyJL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012;18(3):413–421.
37.
KawamuraKChengYSuzukiN, et al.Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci. USA. 2013;110(43):17474–17479.
38.
SchachingerVErbsSElsasserA, et al.Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355(12):1210–1221.
39.
VanikarAVTrivediHLThakkarUG. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus. Cytotherapy. 2016;18(9):1077–1086.
40.
HiguchiAKumarSSBenelliG, et al.Stem cell therapies for reversing vision loss. Trends Biotechnol. 2017;35(11):1102–1117.
41.
FreitagJWickhamJShahKTenenA. Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of acromioclavicular joint osteoarthritis. BMJ Case Rep. 2019;12(2):pii: e227865.
42.
Optimizing natural fertility: A committee opinion. Fertil and Steril. 2017;107(1):52–58.
43.
ChoiKHJooBSSunST, et al.Administration of visfatin during superovulation improves developmental competency of oocytes and fertility potential in aged female mice. Fertil Steril. 2012;97(5):1234–1241.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
